---
name: data-visualization
description: ANALYST-owned skill for designing and specifying data visualizations across clinical outcomes, benchmark comparisons, longitudinal trends, population distributions, and safety data. Covers chart type selection, narrative framing, interactive patterns, and PPN-specific domain rules. Use when any chart, graph, dashboard panel, or visual data story is needed.
---

# ğŸ“Š Data Visualization Skill
**Owner: ANALYST**

> *"The goal is not to show data. The goal is to make the right people see the right thing at the right moment and take the right action."*

---

## ğŸ¯ When to Use This Skill

Activate this skill when:
- Specifying a new chart, graph, or visualization for any PPN page
- Reviewing whether a chosen chart type actually fits the data shape
- Designing the Analytics page, benchmark cards, or population comparison views
- Turning a raw data question ("how are our outcomes?") into a specific visual answer
- Auditing existing charts for misleading patterns or bad defaults

---

## ğŸ§  ANALYST's First Law of Visualization

**Never choose a chart type before answering these four questions:**

1. **What comparison are we making?** (composition, distribution, trend, relationship, deviation)
2. **How many variables?** (1, 2, or N-dimensional)
3. **What is the time frame?** (single point, before/after, longitudinal, cohort)
4. **Who is the audience?** (practitioner, clinic admin, researcher, investor, regulator)

If you cannot answer all four, you are not ready to specify a chart. Ask first.

---

## ğŸ“ Chart Type Selection Matrix

### Category: COMPOSITION (What makes up the whole?)
| Use Case | Chart Type | Never Use |
|----------|-----------|-----------|
| % breakdown at one point in time | Donut chart (max 5 slices) | Pie chart with >5 categories |
| % breakdown across multiple groups | Grouped bar chart | Stacked 100% area (hard to read) |
| Part-whole with hierarchy | Treemap | Nested pies |
| Patient condition mix | Horizontal bar with labels | Vertical bar (labels overlap) |

### Category: DISTRIBUTION (How is data spread?)
| Use Case | Chart Type | Never Use |
|----------|-----------|-----------|
| Single score distribution | Histogram with rug plot | Bar chart (wrong encoding) |
| Score distribution across groups | Box-and-whisker / violin | Mean-only bar (hides spread) |
| Response rate spread | Dot plot (individual) | Average line alone |
| Adverse event severity distribution | Strip chart with jitter | Stacked bar |

### Category: TREND (How does it change over time?)
| Use Case | Chart Type | Never Use |
|----------|-----------|-----------|
| Outcome score longitudinal | Line chart with confidence band | Bar chart for time series |
| Multiple patients tracked | Spaghetti plot (N<20) or summary ribbon | Overplotted scatter |
| Cohort retention over weeks | Step-area chart | Pie-over-time |
| Pre/post single intervention | Paired dot plot (slope chart) | Bar with error bars |

### Category: COMPARISON (How do groups differ?)
| Use Case | Chart Type | Never Use |
|----------|-----------|-----------|
| Your clinic vs. benchmark | Diverging bar or bullet chart | Raw number tables |
| Multiple clinics vs. global | Lollipop chart with reference line | Grouped bar >5 groups |
| Effect sizes across studies | Forest plot | Standard bar |
| Score change (delta) | Waterfall chart | Absolute score chart |

### Category: RELATIONSHIP (Do variables move together?)
| Use Case | Chart Type | Never Use |
|----------|-----------|-----------|
| Two continuous variables | Scatter with regression line | Line chart (implies time) |
| Correlation matrix | Clustered heatmap | Correlation table |
| Dose-response relationship | Connected scatter | Bar chart |
| Adverse events vs. dosage | Bubble chart | Standard scatter |

---

## ğŸ¥ PPN-Specific Domain Rules

### Rule 1: Always Show N (Sample Size)
Every chart MUST display the sample size somewhere prominent. A 90% response rate from N=5 is not the same as N=500.

```
âœ… "Response Rate: 87% (n=143)"
âŒ "Response Rate: 87%"
```

### Rule 2: Show Uncertainty â€” Always
No clinical chart should ever show a point estimate alone. Include:
- Confidence intervals (95% CI preferred)
- Standard deviations for distributions
- Standard errors for means
- Range bars for small samples

### Rule 3: Benchmark Lines Are Mandatory on Outcome Charts
Any chart showing PPN practitioner outcomes MUST include:
- A horizontal reference line at the **published clinical trial benchmark** (labeled)
- A horizontal reference line at the **naturalistic/real-world benchmark** (labeled)
- A visual zone marking clinically meaningful improvement threshold (e.g., MADRS â‰¥50% reduction)

### Rule 4: Score Direction Must Be Unambiguous
Clinical scales can go in either direction. Always annotate:
- Arrow or label: "Lower = Better" or "Higher = Better"
- For PTSD, depression, anxiety scales: lower is always better
- For functioning, well-being, quality of life: higher is better

### Rule 5: Time Axis Baseline Is Session Zero
Never start the time axis at a calendar date for clinical charts. Always use:
- "Week 0" = baseline (before intervention)
- "Week 1", "Week 3", "Week 6", "Week 12" = standard follow-up windows

### Rule 6: No Rainbow Color Scales
Color scales for sequential data must be:
- **Sequential (lightâ†’dark):** Single hue ramp (e.g., blues, teals)
- **Diverging:** Two-hue from midpoint (e.g., purple â†” orange)
- **Categorical:** Max 6 colors, all distinguishable by users with deuteranopia

Approved palettes for PPN (all WCAG AA compliant, colorblind-safe):
```
Categorical:   #3b82f6 (blue), #f59e0b (amber), #8b5cf6 (violet), #06b6d4 (cyan), #f97316 (orange), #84cc16 (lime)
Sequential:    #0c4a6e â†’ #38bdf8   (sky blue scale)
Diverging:     #7c3aed â†” #ea580c   (violet â†’ orange)
Alert/Error:   Use text label [ALERT] + amber color, never red/green alone
```

---

## ğŸ“Š PPN Signature Chart Patterns

### Pattern 1: The Benchmark Ribbon (Flagship)
**Use for:** Showing a clinic's outcomes against global evidence

**Components:**
1. Primary line: Clinic's mean score at each timepoint (with shaded CI)
2. Ribbon zone: Clinical trial benchmark range (shaded, labeled "Phase 3 Trial Range")
3. Dashed line: Naturalistic/real-world benchmark (labeled "Real-World Average N=8,000")
4. Threshold line: Clinically meaningful improvement marker
5. Response/remission labels at final timepoint

```
Score
  â”‚
40â”‚  â—â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â—   â† Phase 3 Range (shaded)
  â”‚  
32â”‚  â—‹ â† Clinic Baseline                       â† Real-World Avg (dashed)
  â”‚     â•²
24â”‚      â•²â”â”â”â”â”â—â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â—  â† Clinic Line
  â”‚             
16â”‚â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”  â† Clinically Meaningful Threshold
  â”‚
  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
    Week 0    Week 3    Week 6    Week 12
```

**Instruments to use this pattern for:**
- MADRS (depression, lower = better)
- PHQ-9 (depression, lower = better)
- CAPS-5 (PTSD, lower = better)
- GAD-7 (anxiety, lower = better)
- QIDS-SR-16 (depression, lower = better)

---

### Pattern 2: The Population Funnel
**Use for:** Showing how many patients reach each milestone

**Components:**
- Full-width bar: Total enrolled
- Narrowing bars: Completed baseline â†’ completed session â†’ completed follow-up â†’ improved â†’ responded â†’ remitted
- Dropout annotation at each stage with reason distribution

---

### Pattern 3: Safety Scatter (Dose-Response)
**Use for:** Adverse events vs. session variables

**Components:**
- X-axis: Dose (mg) or session duration (minutes)
- Y-axis: Adverse event severity grade (1â€“4)
- Bubble size: Frequency
- Color: Modality (following categorical palette above)
- Quadrant annotations: Safe Zone / Monitor Zone / Alert Zone

---

### Pattern 4: Global Cohort Heatmap
**Use for:** Comparing outcomes across conditions Ã— modalities matrix

**Components:**
- Rows: Conditions (PTSD, MDD, TRD, AUD, OUD, Anxiety, Burnout)
- Columns: Modalities (Psilocybin, MDMA, Ketamine, Esketamine)
- Cell value: Mean effect size (Hedges' g) from global benchmark data
- Cell color: Diverging scale (small â†’ large effect size)
- Cell label: "g = 0.91 (n=2,847)"
- Hover tooltip: Cite the source study

---

### Pattern 5: Before / After Paired Slope Chart
**Use for:** Individual-level pre/post outcomes within a cohort

**Components:**
- Each patient = one line connecting baseline dot to endpoint dot
- Line slope direction: Down = improvement (for symptom scales)
- Line color: Response status (responded / not responded) â€” with text label
- Median slope line: Bold, annotated
- Reference lines: Clinically meaningful change threshold

---

## ğŸ¬ Narrative Framing (Analytical Storytelling)

Every visualization must have an **insight headline** â€” not a description, but a conclusion:

```
âŒ "MADRS scores over time by arm"
âœ… "Psilocybin patients improved 3.2Ã— faster than clinical trial benchmarks at Week 3"

âŒ "Response rate by modality"  
âœ… "MDMA shows highest PTSD response rate in your clinic â€” outpacing published Phase 3 data"

âŒ "Adverse events by severity"
âœ… "99.1% of sessions completed without a Grade 3+ adverse event â€” consistent with trial safety profiles"
```

Rules for headlines:
1. Always include a specific number
2. Always include a comparison (to what? vs. when? vs. whom?)
3. Write for the practitioner, not the statistician
4. Never imply causation. Use "associated with" not "caused by"

---

## ğŸ”§ Technical Specifications

### Preferred Libraries (PPN Stack)
```typescript
// Primary: Recharts (standard charts)
import { LineChart, AreaChart, ScatterChart, RadarChart, ComposedChart } from 'recharts';

// Secondary: D3 (custom SVG â€” forest plots, slope charts, heatmaps)
import * as d3 from 'd3';

// Annotation layer: recharts-reference-lines + custom SVG overlays

// Color: d3-scale-chromatic (colorblind-safe palettes)
import { schemeTableau10 } from 'd3-scale-chromatic';
```

### Responsive Container â€” Always Use
```tsx
<ResponsiveContainer width="100%" height={height ?? 320}>
  {/* chart here */}
</ResponsiveContainer>
```

### Custom Tooltip Template
```tsx
const ClinicalTooltip = ({ active, payload, label }) => {
  if (!active || !payload?.length) return null;
  return (
    <div className="bg-slate-800 border border-slate-600 rounded-lg p-3 text-sm shadow-xl">
      <p className="text-slate-400 mb-1 font-medium">{label}</p>
      {payload.map((entry) => (
        <div key={entry.name} className="flex justify-between gap-4">
          <span className="text-slate-300">{entry.name}:</span>
          <span className="text-white font-bold">{entry.value}</span>
        </div>
      ))}
      {payload[0]?.payload?.n && (
        <p className="text-slate-500 text-xs mt-1">n = {payload[0].payload.n}</p>
      )}
      {payload[0]?.payload?.source && (
        <p className="text-slate-500 text-xs">Source: {payload[0].payload.source}</p>
      )}
    </div>
  );
};
```

### Loading & Error States
```tsx
// Always wrap charts in error boundary + loading skeleton
{isLoading ? (
  <div className="animate-pulse bg-slate-700/30 rounded-xl h-64" />
) : error ? (
  <div className="text-slate-400 text-sm text-center py-8">
    [STATUS: FAIL] Unable to load chart data. Retry?
  </div>
) : (
  <ResponsiveContainer>{/* chart */}</ResponsiveContainer>
)}
```

---

## âœ… ANALYST Pre-Handoff Checklist

Before handing any visualization spec to BUILDER or DESIGNER:

- [ ] Chart type matches the comparison type (composition / distribution / trend / relationship)
- [ ] Sample size (n) is visible on or near every chart
- [ ] Uncertainty (CI, SD, SE) is shown â€” never a bare point estimate
- [ ] Benchmark reference lines are included for all outcome charts
- [ ] Score direction is labeled ("Lower = Better")
- [ ] Color palette is from the approved colorblind-safe set
- [ ] Insight headline is written (specific number + comparison)
- [ ] Source/citation is stored in the data and shown in tooltip
- [ ] Responsive container is specified
- [ ] Loading and error states are defined

---

## ğŸš« Absolute Prohibitions

| Never Do This | Do This Instead |
|--------------|-----------------|
| Pie chart with >4 categories | Horizontal bar chart ranked by value |
| Y-axis that doesn't start at 0 (for bar charts) | Start at 0; use dot/line for change |
| Dual Y-axis (two different scales on same chart) | Two separate charts, synchronized |
| 3D charts of any kind | 2D with depth implied by size/color |
| Animation that obscures data (spin, bounce) | Simple fade-in on load only |
| Truncated axis to "make change look bigger" | Full scale with annotation of change magnitude |
| Color without text label for status | Text label required alongside color |
| Average without spread | Mean Â± SD or CI band always |
| Comparing raw N across studies with different enrollment | Normalize to effect size or percentage |

---

**END OF DATA VISUALIZATION SKILL**
